Publications by authors named "Ilya Yu Vasiliev"

Imbalanced nutrition, such as a high-fat/high-carbohydrate diet, is associated with negative effects on human health. The composition and metabolic activity of the human gut microbiota are closely related to the type of diet and have been shown to change significantly in response to changes in food content and food supplement administration. Alkylresorcinols (ARs) are lipophilic molecules that have been found to improve lipid metabolism and glycemic control and decrease systemic inflammation.

View Article and Find Full Text PDF

Currently, obesity is a critical global public health burden. Numerous studies have demonstrated the regulation of the pathogenesis of obesity and metabolic abnormalities by the gut microbiota and microbial factors; however, their involvement in the various degrees of obesity is not yet well understood. Previously, obesity has been shown to be associated with decreased levels of vitamin B12.

View Article and Find Full Text PDF

Alkylresorcinols (ARs) are polyphenolic compounds with a wide spectrum of biological activities and are potentially involved in the regulation of host metabolism. The present study aims to establish whether ARs can be produced by the human gut microbiota and to evaluate alterations in content in stool samples as well as metabolic activity of the gut microbiota of C57BL, , and LDLR (-/-) mice according to diet specifications and olivetol (5-n-pentylresorcinol) supplementation to estimate the regulatory potential of ARs. Gas chromatography with mass spectrometric detection was used to quantitatively analyse AR levels in mouse stool samples; faecal microbiota transplantation (FMT) from human donors to germ-free mice was performed to determine whether the intestinal microbiota could produce AR molecules; metagenome sequencing analysis of the mouse gut microbiota followed by reconstruction of its metabolic activity was performed to investigate olivetol's regulatory potential.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the gut microbiota and IBD biomarkers in patients from Kazan, Russia, addressing the growing interest in IBD in newly industrialized countries.* -
  • Researchers found significant changes in the gut microbiota of IBD patients, including increased levels of certain bacteria and decreased levels of beneficial species, indicating a dysbiotic state.* -
  • The findings suggest that these changes, particularly the imbalance of short-chain fatty acids (SCFAs), may impact important metabolic processes like hydrogen metabolism, which is crucial for understanding the disease.*
View Article and Find Full Text PDF